Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
Health & Biotech
US FDA approval is on the agenda for these 5 ASX small caps
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
New investors back HeraMed’s latest raise to the tune of $2.3m
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
HeraMED gets set for Aussie clinical trials with new deal
Health & Biotech
HeraMED ramps up Australian strategy with new distribution deal
News
V-Con Recap: Here are the most important things we learned about the future of telehealth
Stockhead TV
Stockhead V-Con: The Future of TeleHealth
Health & Biotech
HeraMED scores major boost in the US market, following a landmark FDA ruling
News
Going Viral: All the best COVID-19 news from the week
Health & Biotech
StockDoc Podcast: HeraMED’s telehealth offering for pregnant women is booming under COVID-19
Stockhead TV
Stock Talk: TeleHealth in a COVID-19 world and beyond
News
Lunchtime ASX small cap wrap: Who’s ready for a stimulus package today?
Tech
Remote control: 5 medtechs set to benefit from the surge in demand for tele-health solutions
Health & Biotech
HeraMED’s hybrid maternity care platform poised for market testing
Health & Biotech